IL10 and neoplasm: Besides, M2-type tumor-associated macrophages (TAMs) secrete inhibitory cytokines under tumor hypoxic conditions, such as transforming growth factor-β and interleukin-10 (IL-10), which together constitute an inhibitory immune TME to block the entry of killer immune cells [17,18].